Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Medical Developments International Limited
  6. Summary
    MVP   AU000000MVP2

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

(MVP)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
12/02/2021 12/03/2021 12/06/2021 12/07/2021 12/08/2021 Date
4.94 4.95 5 5.08 5.2 Last
65059 192098 35770 88568 274824 Volume
+1.44% +0.20% +1.01% +1.60% +2.36% Change
Estimated financial data (e)
Sales 2022 25,7 M 18,4 M 18,4 M
Net income 2022 -7,05 M -5,05 M -5,05 M
Net cash position 2022 19,4 M 13,9 M 13,9 M
P/E ratio 2022 -52,5x
Yield 2022 -
Sales 2023 46,8 M 33,5 M 33,5 M
Net income 2023 -1,70 M -1,22 M -1,22 M
Net Debt 2023 4,30 M 3,08 M 3,08 M
P/E ratio 2023 -221x
Yield 2023 0,38%
Capitalization 371 M 266 M 266 M
EV / Sales 2022 13,7x
EV / Sales 2023 8,01x
Nbr of Employees -
Free-Float 80,0%
More Financials
Company
Medical Developments International Limited is an Australia-based healthcare company. The Company is focused on manufacturing and distributing pharmaceutical drugs, and medical and veterinary equipment. The Company operates through three segments: Pharmaceuticals, Medical Devices and Veterinary Products. The Pharmaceuticals segment is engaged in the sale of Penthrox primarily within Australia, New Zealand, Europe and... 
Sector
Pharmaceuticals
Calendar
02/23Earnings Release
More about the company
Ratings of Medical Developments International Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
09/20MEDICAL DEVELOPMENTS INTERNATIONAL L : MVP) added to S&P/ASX Emerging Companies Index
CI
09/20MEDICAL DEVELOPMENTS INTERNATIONAL L : MVP) dropped from S&P/ASX Small Ordinaries Index
CI
09/20MEDICAL DEVELOPMENTS INTERNATIONAL L : MVP) dropped from S&P/ASX 300 Index
CI
08/24Medical Developments International Limited Provides Sales Guidance for the Fiscal Year ..
CI
07/15Medical Developments International Limited Announces Earnings Guidance for the Year End..
CI
05/10Medical Developments International Limited Appoints Richard Betts as Non-Executive Dire..
CI
03/04Medical Developments International Limited Appoints Mary Sontrop as Non-Executive Direc..
CI
02/26Aussie Shares Fall Amid IT Selloff; Australia's Total Credit Slows Growth in January
MT
02/25MEDICAL DEVELOPMENTS INTERNATIONAL : Swings to Loss in July-December 2020
MT
02/25Medical Developments International Limited Reports Earnings Results for the Half Year E..
CI
2020MEDICAL DEVELOPMENTS INTERNATIONAL : Raises $3.8 Million in Share Purchase Program
MT
2020Medical Developments International Limited Announces Executive Changes
CI
2020MEDICAL DEVELOPMENTS INTERNATIONAL : Cancels Distribution Agreement With MundiPharma for P..
MT
2020Medical Developments International Limited Appoints Brent Macgregor as Chief Executive ..
CI
2020Medical Developments International Limited Announces the Appointment of Gordon Naylor a..
CI
More news
News in other languages on MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
08/24Medical Developments International Limited fournit des indications sur les ventes pour ..
07/15Medical Developments International Limited annonce ses prévisions de bénéfices pour l'e..
02/26Les actions australiennes chutent dans un contexte de repli des technologies de l'infor..
02/25Medical Developments International passe à la perte en juillet-décembre 2020
2020Medical Developments International lève 3,8 millions de dollars dans le cadre d'un prog..
More news
Chart MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Duration : Period :
Medical Developments International Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 5,20 AUD
Average target price 4,90 AUD
Spread / Average Target -5,77%
EPS Revisions
Managers and Directors
Brent MacGregor Chief Executive Officer
Mark Edwards Chief Financial Officer & Secretary
Gordon Naylor Non-Executive Chairman
Scott Courtney Chief Scientific Officer
Michelle Bradney Head-Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED-22.16%258
JOHNSON & JOHNSON3.80%430 061
ROCHE HOLDING AG19.17%324 115
PFIZER, INC.39.85%290 297
NOVO NORDISK A/S70.26%250 392
ELI LILLY AND COMPANY45.17%222 215